Investigator
Michael James Emanuele
UNIV OF NORTH CAROLINA CHAPEL HILL · funded by NIGMS
- Companies
- 1
- Grants
- 3
- Non-dilutive funding
- $1.7M
- First award
- Jul 1, 2020
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Apr 1, 2024.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- MiNDERA Corp57momentum
OncologyFormed
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R35
Proteostasis signaling in cell cycle control
$581kApr 1, 2024NIGMSUNIV OF NORTH CAROLINA CHAPEL HILLNIH RePORTER · 11055986 (opens the source filing in a new tab)
- R35
Proteostasis signaling in cell cycle control
$581kApr 1, 2024NIGMSUNIV OF NORTH CAROLINA CHAPEL HILLNIH RePORTER · 11324552 (opens the source filing in a new tab)
- T32
Pharmacological Sciences Training Program
$534kJul 1, 2020NIGMSUNIV OF NORTH CAROLINA CHAPEL HILLNIH RePORTER · 11016572 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources